Nuria Bonifaci

Madrid, MD 28029, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Multiplexed CRISPR/Cas9 Editing of Tumor Suppressor Genes in the Mouse Endometrium Recapitulates High-Risk Endometrial Carcinoma.

Multiplexed CRISPR/Cas9 Editing of Tumor Suppressor Genes in the Mouse Endometrium Recapitulates High-Risk Endometrial Carcinoma.

Journal: Cancer communications (London, England)
Published: November 04, 2025

miR-424(322)~503 impairs colon cancer progression driven by PTEN deficiency.

miR-424(322)~503 impairs colon cancer progression driven by PTEN deficiency.

Journal: Cell death & disease
Published: August 21, 2025

ARID1A deficiency reprograms the tumor secretome, enhancing microenvironmental remodeling and metastatic dissemination in endometrial carcinoma.

ARID1A deficiency reprograms the tumor secretome, enhancing microenvironmental remodeling and metastatic dissemination in endometrial carcinoma.

Journal: Cell death & disease
Published: July 07, 2025

Endometrial cancer progression driven by PTEN-deficiency requires miR-424(322)~503.

Endometrial cancer progression driven by PTEN-deficiency requires miR-424(322)~503.

Journal: Cell death & disease
Published: April 11, 2025

Ability of a polygenic risk score to refine colorectal cancer risk in Lynch syndrome.

Ability of a polygenic risk score to refine colorectal cancer risk in Lynch syndrome.

Journal: Journal of medical genetics
Published: April 21, 2023

MTHFR C677T and A1298C polymorphism's effect on risk of colorectal cancer in Lynch syndrome.

MTHFR C677T and A1298C polymorphism's effect on risk of colorectal cancer in Lynch syndrome.

Journal: Scientific reports
Published: March 11, 2023

Oxidative stress-induced FAK activation contributes to uterine serous carcinoma aggressiveness.

Oxidative stress-induced FAK activation contributes to uterine serous carcinoma aggressiveness.

Journal: Molecular oncology
Published: September 12, 2022

Generation and Integrated Analysis of Advanced Patient-Derived Orthoxenograft Models (PDOX) for the Rational Assessment of Targeted Therapies in Endometrial Cancer.

Generation and Integrated Analysis of Advanced Patient-Derived Orthoxenograft Models (PDOX) for the Rational Assessment of Targeted Therapies in Endometrial Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 22, 2022

Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer.

Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer.

Journal: Cancers
Published: May 05, 2022

A microRNA Cluster Controls Fat Cell Differentiation and Adipose Tissue Expansion By Regulating SNCG.

A microRNA Cluster Controls Fat Cell Differentiation and Adipose Tissue Expansion By Regulating SNCG.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 22, 2021

ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma.

ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma.

Journal: Molecular oncology
Published: September 23, 2021

Non-Lynch Familial and Early-Onset Colorectal Cancer Explained by Accumulation of Low-Risk Genetic Variants.

Non-Lynch Familial and Early-Onset Colorectal Cancer Explained by Accumulation of Low-Risk Genetic Variants.

Journal: Cancers
Published: May 10, 2021
Showing 1-12 of 23

Last Updated: 09/26/2026